Abstract
Probenecid blocks the efflux of 5-hydroxyindole acetic acid (5-HIAA) from the central nervous system, and has therefore been used for turnover measurements of central 5-hydroxytryptamine (5-HT). This substance also elevates tryptophan (TP) levels in rat brain. In this investigation, the time courses of probenecid and TP levels in rat serum and brain after administration of probenecid were studied. Maximal levels of probenecid were reached within 15 min, followed by a 50% decrease of serum TP and a 40% increase of brain TP. Brain levels of probenecid were about ten times lower than those in serum. Because TP level in brain is an important factor in the control of cerebral 5-HT synthesis, the effects of probenecid on 5-HT formation in rat brain were investigated. By means of the aromatic l-amino acid decarboxylase inhibitors Ro 4-4602 and NSD 1015, an enhancement of TP hydroxylation of about 35% was demonstrated.
Is was concluded that penetration of probenecid into the brain is very limited and that probenecid, in addition to blocking egress of 5-HIAA from the CNS, stimulates 5-HT synthesis.
Similar content being viewed by others
References
Andersson, H., Von Essen, C., Roos, B.-E.: On the elimination of 5-hydroxyindoleacetic acid and homovanillic acid from cerebrospinal fluid. Acta Pharmacol. Toxicol. 32, 129–138 (1973)
Ashcroft, G. W., Dow, R. C., Moir, A. T. B.: The active transport of 5-hydroxyindol-3-ylacetic acid and 3-methoxy-4-hydroxypheylacetic acid from a recirculatory perfusion system of the cerebral ventricles of the unanaesthetized dog. J. Physiol. 199, 397–425 (1968)
Atack, C. V., Lindqvist, M.: Conjoint and native orthophthaldialdehyde condensate assays for the fluorometric determinations of 5-hydroxyindoles in brain. Naunyn-Schmiedebergs Arch. Pharmacol. 279, 267–284 (1973)
Bowers, Jr., M. B.: 5-Hydroxyindoleacetic acid (5HIAA) and homovanillic acid (HVA) following probenecid in acute psychotic patients treated with phenothiazines. Psychopharmacologia (Berl.) 28, 309–318 (1973)
Bowers, Jr., M. B.: Fluorometric measurement of 5-hydroxyindoleacetic acid (5-HIAA) and tryptophan in human CSF: effects of high doses of probenecid. Biol. Psychiatry 9, 93–97 (1974)
Bruinvels, J.: Inhibition of the biosynthesis of 5-hydroxytryptamine in rat brain by imipramine. Eur. J. Pharmacol. 20, 231–237 (1972)
Carlsson, A.: Measurements of monoamine sythesis and turnover with special reference to 5-hydroxytryptamine. Adv. Biochem. Psychopharmacol. 10, 75–81 (1974)
Carlsson, A., Davis, J. N., Kehr, W., Lindqvist, M., Atack, C. V.: Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in vivo using an inhibitor of the aromatic amino acid decarboxylase. Naunyn-Schmiedebergs Arch. Pharmacol. 275, 153–168 (1972)
Carlsson, A., Lindqvist, M.: The effect of L-tryptophan and some psychotropic drugs on the formation of 5-hydroxytryptophan in the mouse brain in vivo. J. Neural Transm 33, 23–43 (1972)
Carlsson, A., Lindqvist, M.: In-vivo measurements of tryptophan and tyrosine hydroxylase activities in mouse brain. J. Neural Transm. 34, 79–91 (1973)
Eccleston, D., Ashcroft, G. W., Crawford, T. B. B., Stanton, J. B., Wood, D., McTurk, P. H.: Effect of tryptophan administration on 5-HIAA in cerebrospinal fluid in man. J. Neurol. Neurosurg. Psychiatry. 33, 269–272 (1970)
Fernstrom, J. D., Hirsch, M. J.: Brain serotonin synthesis: reduction in corn-malnourished rats. J. Neurochem 28, 877–879 (1977)
Fernstrom, J. D., Wurtman, R. J.: Brain serotonin content: physiological regulation by plasma neutral amino acids. Science 178, 414–416 (1972)
Gessa, G. L., Biggio, G., Tagliamonte, A.: Brain serotonin turnover: dependence on free tryptophan concentration in plasma. Fed. Proc. 31, 599 (1972)
Gessa, G. L., Tagliamonte, A.: Possible role of free serum tryptophan in the control of brain tryptophan level and serotonin synthesis. Adv. Biochem. Psychopharmacol. 11, 119–131 (1974)
Grahame-Smith, D. G.: Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan. J. Neurochem. 18, 1053–1066 (1971)
Kartzinel, R., Ebert, M. H., Chase, Th. N.: Intravenous probenecid loading. Effects on plasma and cerebrospinal fluid probenecid levels and on monoamine metabolites in cerebrospinal fluid. Neurology 26, 992–996 (1976)
Knott, P. J., Curzon, G.: Free tryptophan in plasma and brain tryptophan metabolism. Nature, 239, 452–453 (1972)
Korf, J., Kuiper, H. E.: Induction of bizarre behaviour in rats by pchloroamphetamine, a serotonin depletor, after repeated drug administration. Psychopharmacologia (Berl.) 21, 328–337 (1971)
Korf, J., Van Praag, H. M.: Amine metabolism in the human brain: further evaluation of the probenecid test. Brain Res. 35, 221–230 (1971)
Korf, J., Van Praag, H. M., Sebens, J. B.: Serum tryptophan decreased, brain tryptophan increased and brain serotonin synthesis unchanged after probenecid loading. Brain Res. 42, 239–242 (1972)
Lewander, T., Sjöström, R.: Increase in the plasma concentration of free tryptophan caused by probenecid in humans. Psychopharmacologia (Berl.) 33, 81–86 (1973)
Lin, R. C., Costa, E., Neff, N. H., Wang, C. T., Ngai, S. H.: In vivo measurement of 5-hydroxytryptamine turnover rate in the rat brain from the conversion of C14-tryptophan to C14-5-hyroxytryptamine. J. Pharmacol. Exp. Ther. 170, 232–238 (1969)
Macon, J. B., Sokoloff, L., Glowinski, J.: Feedback control of rat brain 5-hydroxytryptamine synthesis. J. Neurochem. 18, 323–331 (1971)
Meek, J. L., Neff, N. H.: The rate of formation of 3-methoxy-4-hydroxyphenylethyleneglycol sulfate in brain as an estimate of the rate of formation of norepinephrine. J. Pharmacol. Exp. Ther. 184, 570–575 (1973)
Meek, J., Werdinius, B.: 5-Hydroxytryptamine turnover decreased by the antidepressant drug chlorimipramine. J. Pharm. Pharmacol. 22, 141–143 (1970)
Morot-Gaudry, Y., Hamon, M., Bourgoin, S., Ley, J. P., Glowinski, J.: Estimation of the rate of 5-HT synthesis in the mouse brain by various methods. Nauyn-Schmiedebergs Arch. Pharmacol. 282, 223–238 (1974)
Muizelaar, J. P., Oberink, J. I.: Probenecid: dosage, levels in plasma and cerebrospinal fluid (CSF) and influence upon CSF levels of homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) in the rabbit. Psychopharmacologia (Berl.) 43, 223–227 (1975)
Neff, N. H. Tozer, Th. N., Brodie, B. B.: Application, of steady-state kinetics to studies of the transfer of 5-hydroxyindoleacetic acid from brain to plasma. J. Pharmacol. Exp. Ther. 158, 214–218 (1967)
Olsson, R., Roos, B.-E.: Concentrations of 5-hydroxyindole acetic acid and homovanillic acid in the cerebrospinal fluid after treatment with probenecid in patients with Parkinson's disease. Nature 219, 502–503 (1968)
Perel, J. M., Levitt, M., Dunner, D. L.: Plasma and cerebrospinal fluid probenecid concentrations as related to accumulation of acidic biogenic amine metabolites in man. Psychopharmacologia (Berl.) 35, 83–90 (1974)
Post, R. M., Goodwin, F. K.: Effects of amitriptyline and imipramine on mmine metabolites in the cerebrospinal fluid of depressed patients. Arch. Gen. Psychiatry. 30, 234–239 (1974)
Schubert, J.: Labelled 5-hydroxytryptamine and5-hydroxyindoleacetic acid formed in vivo from 3H-tryptophan in rat brain; effect of probenecid. Acta Physiol. Scand. 90, 401–408 (1974)
Sharman, D. F.: A discussion of the modes of action of drugs which increase the concentration of 4-hydroxy-3-methoxyphenylacetic acid (homovanillic acid) in the striatum of the mouse. J. Pharmacol. Chemother. 30, 620–626 (1967)
Sjöström, R.: Steady-state levels of probenecid and their relation to acid monoamine metabolites in human cerebrospinal fluid. Psychopharmacologia (Berl.) 25, 96–100 (1972)
Tagliamonte, A., Biggio, G., Vargiu, L., Gessa, G. L.: Increase of brain tryptophan and stimulation of serotonin synthesis by salicylate. J. Neurochem. 20, 909–912 (1973)
Tagliamonte, A., Tagliamonte, P., Perez-Cruet, J., Stern, S., Gessa, G. L.: Effect of psychotropic drugs on tryptophan concentration in the rat brain. J. Pharmacol. Exp. Ther. 177, 475–480 (1971)
Tamarkin, N. R., Goodwin, F. K., Axelrod, J.: Rapid elevation of biogenic amine metabolites in human CSF following probenecid. Life Sci. 9, 1397–1408 (1970)
Van der Poel, F. W., Van Praag, H. M., Korf, J.: Evidence for a probenecid-sensitive transport system of acid monoamine metabolites from the spinal subarachnoid space. Psychopharmacology. 52, 35–40 (1977)
Van Praag, H. M., Korf, J., Schut, D.: Cerebral monoamines and depression. An investigation with the probenecid technique. Arch. Gen. Psychiatry 28, 827–831 (1973)
Van Wijk, M., Meisch, J.-J., Korf, J.: Metabolism of5-hydroxytryptamine and levels of tricyclic antidepressant drugs in rat brain after acute and chronic treatment. Psychopharmacologia 55, 217–223 (1977)
Werdinius, B.: Effect of probenecid on the levels of monoamine metabolites in the rat brain. Acta Pharmacol. Toxicol. 25, 18–23 (1967)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van Wijk, M., Sebens, J.B. & Korf, J. Probenecid-induced increase of 5-hydroxytryptamine synthesis in rat brain, as measured by formation of 5-hydroxytryptophan. Psychopharmacology 60, 229–235 (1979). https://doi.org/10.1007/BF00426660
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00426660